Del Global Technologies and its Italian subsidiary, Villa Sistemi Medicali, announced that the government of Lithuania has awarded them an $8.25 million, two-year contract for a variety of x-ray systems.Del Global manufactures general and portable
Del Global Technologies and its Italian subsidiary, Villa Sistemi Medicali, announced that the government of Lithuania has awarded them an $8.25 million, two-year contract for a variety of x-ray systems.
Del Global manufactures general and portable x-ray systems, as well as dental and mammography units. It recently signed an agreement with the European Distribution Organization (SCAN, 8/2/00), granting the EDO the right to act as exclusive distributor of Del Globals medical imaging systems.
Countries in the EDO include Poland, the Czech Republic, the Slovak Republic, Hungary, Greece, Romania, Turkey, Bulgaria, Yugoslavia, Russia, and others, such as Lithuania, in the Commonwealth of Independent States.
Del Global also announced that the FDA has approved marketing of Villa Sistemis dental imaging system in the U.S.
Del Global obtained a 19% stake in Villa Sistemi in January, along with the nonrevocable option to increase its ownership share to 80%, and decided to exercise that option in April (SCAN 5/10/00). Del Global is based in Valhalla, NY, while Villa Sistemi is based in Milan.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.